Dr. Nieuwkamp and colleagues reply

New England Journal of Medicine

Volumn 373, Issue 6, 2015, Pages 584-

  Nieuwkamp, Dennis J ^a   Murk, Jean Luc ^a   Van Oosten, Bob W ^b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FUMARIC ACID DIMETHYL ESTER; FUMARIC ACID DERIVATIVE; IMMUNOSUPPRESSIVE AGENT;

DRUG SAFETY; HUMAN; IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME; INFECTION RISK; LETTER; LYMPHOCYTOPENIA; MULTIPLE SCLEROSIS; OPPORTUNISTIC INFECTION; PATIENT MONITORING; PATIENT SAFETY; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; RISK ASSESSMENT; CHEMICALLY INDUCED; COMPLICATION; FEMALE;

FEMALE; FUMARATES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LYMPHOPENIA;

EID: 84938829260     PISSN: 00284793     EISSN: 15334406     Source Type: Journal    
DOI: 10.1056/NEJMc1506151     Document Type: Letter

References (1)

1. Hoepner R, Faissner S, Klasing A, et al. Progressive multifocal leukoencephalopathy during fumarate monotherapy of psoriasis. Neurol Neuroimmunol Neuroinflamm 2015;2(3):e85.